Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

MLA

Romani, Luigina, et al. “Author Correction: Thymosin Α1 Represents a Potential Potent Single-Molecule-Based Therapy for Cystic Fibrosis.” Nature Medicine, vol. 24, no. 9, Sept. 2018, p. 1481. EBSCOhost, https://doi.org/10.1038/s41591-018-0100-0.

APA

Romani, L., Oikonomou, V., Moretti, S., Iannitti, R. G., D’Adamo, M. C., Villella, V. R., Pariano, M., Sforna, L., Borghi, M., Bellet, M. M., Fallarino, F., Pallotta, M. T., Servillo, G., Ferrari, E., Puccetti, P., Kroemer, G., Pessia, M., Maiuri, L., Goldstein, A. L., & Garaci, E. (2018). Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature Medicine, 24(9), 1481. https://doi.org/10.1038/s41591-018-0100-0

Chicago

Romani, Luigina, Vasilis Oikonomou, Silvia Moretti, Rossana G Iannitti, Maria Cristina D’Adamo, Valeria R Villella, Marilena Pariano, et al. 2018. “Author Correction: Thymosin Α1 Represents a Potential Potent Single-Molecule-Based Therapy for Cystic Fibrosis.” Nature Medicine 24 (9): 1481. doi:10.1038/s41591-018-0100-0.